Sangamo BioSciences Inc. (SGMO) Shares Active after Upgrade at Zacks Investment Research

Sangamo BioSciences Inc. (NASDAQ: SGMO) shares slid back in value Thursday Dec 22 with lighter trade volume than normal after a number of analysts weighed in on the investing value of the stock with a upgraded rating.

Meanwhile, U.S. stocks opened mostly flat on Thursday. The Dow Jones Industrial Average DJIA, -0.15% fell 15 points to 19,928, a drop of less than 0.1%. The S&P 500 SPX, -0.22% fell 1 point, or 0.05%, to 2,264. The Nasdaq Composite Index COMP, -0.23% fell 1 point to 5,470.21, essentially unchanged on the day.

Analysts at Zacks Investment Research upgraded shares of Sangamo BioSciences Inc. (NASDAQ: SGMO) from Sell to Hold today. The company currently has a rating of Hold on the stock. The one-year price target of $7.00 is higher than the opening price of $3.35, that has caused a number of other analysts to issue statements on the company in recent days. Looking back over the last 52 weeks, Sangamo BioSciences Inc. stock has a high of $9.55. Stock prices often trend to the upside on recommendations and new price targets of professional analysts.

Sangamo BioSciences Inc. (NASDAQ: SGMO) shares last traded at $3.18, a decrease of $0.08 per share or -2.31% compared to the previous closing price. Opening at $3.35, they fluctuated from $3.05 and $3.35 throughout the day.

Sangamo BioSciences Inc. (NASDAQ: SGMO) now has a market cap of 224.23M.

Sangamo BioSciences Inc. (NASDAQ: SGMO) Average Daily Trading Volume

39,843 shares traded hands yesterday, lower than the average, out of a total float 64,577,000. Look for trading volume to pick up in the coming days as investors often use increases in trading volume to identify heavy volume aggregation or distribution by institutional investors.

As with all possible breakouts, investors watch for volume to be at least 40%-50% higher than normal on the breakout to demonstrate that fund managers and other professional investors are jumping in.

Institutional sponsorship is defined by ownership of a stock by mutual funds, banks, pension funds and other large institutions.

These professional investors retain teams of analysts researching thousands of stocks, so it is good corroboration to see them buying a stock you’re considering.

Sangamo BioSciences Inc. (NASDAQ: SGMO) Moving Averages

A moving average can also act as support or resistance. In an uptrend a 50-day, 100-day or 200-day moving average may act as a support level, as shown in the figure below.

This is because the average acts like a floor (support), so the price bounces up off of it.

In a downtrend a moving average may act as resistance; like a ceiling, the price hits it and then starts to drop again.

By marking the activity of these professional investors—and the moving averages they influence— traders are able to make make smarter trades.

With that in mind, Sangamo BioSciences Inc. (NASDAQ: SGMO) now has a 50-day MA of $3.51 and 200-day MA of $4.66. It has traded in a 52-week range between $2.65 – 9.550 and today’s last price is 66.75%% lower than the 52 week high of $9.55.

Earnings growth is a crucial factor to consider when investing in stocks and investors seek companies that have grown their earnings at least 25% or more for the past 3 years.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of the website. Readers should not consider statements made by the author as formal recommendations and should consult their financial adviser before making any investment decisions. To read our full disclosure, please see our terms and conditions page.

Leave a Reply

Your email address will not be published. Required fields are marked *